CTH and astrocytoma (excluding glioblastoma): Concerning cystathionine gamma-lyase (CTH), a selective CTH inhibitor has been found to specifically target the active site, showing high sensitivity in IDH1 mutant astrocytomas (Echizen et al., 2023).